Saniona AB Faces Financial Shift Amid Convertible Conversion by Fenja Capital
Saniona AB, a Danish biopharmaceutical company, faces financial challenges after Fenja Capital’s request to convert outstanding convertibles, potentially impacting investor sentiment and stock performance.
3 minutes to read